Current issues in pediatric lupus nephritis: Role of revised histopathological classification

Fetal and Pediatric Pathology

Volumn 25, Issue 6, 2006, Pages 297-309

  Marks, Stephen D ^a,b   Tullus, Kjell ^a,b   Sebire, Neil J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Classification; Etiology; Lupus nephritis; Prognosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB;

CLINICAL FEATURE; CLINICAL RESEARCH; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL DECISION MAKING; MEDICAL SOCIETY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; WORLD HEALTH ORGANIZATION;

CHILD; HUMANS; LUPUS NEPHRITIS; PROGNOSIS;

EID: 34548413533     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.1080/15513810701209512     Document Type: Review

References (45)

1. Kyttaris VC, Katsiari CG, Juang YT, Tsokos GC. New insights into the pathogenesis of systemic lupus erythematosus. Curr Rheumatol Rep 7(6):469-475, 2005.
2. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57(8):456-459, 1998.
3. Lehman TJ, McCurdy DK, Bernstein BH, King KK, Hanson V. Systemic lupus erythematosus in the first decade of life. Pediatrics 83(2):235-239, 1989.
4. Marini R, Costallat LT. Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus. Rev Rhum Engl Ed 66(6):303-309, 1999.
5. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 61(5):409-413, 2002.
6. Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 16(5):577-587, 2004.
7. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34(9):866-872, 1995.
8. Cameron JS. Lupus nephritis in childhood and adolescence. Pediatr Nephrol 8(2):230-249, 1994.
9. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 7(6):924-929, 1996.
10. Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 19(1):36-44, 2004.
11. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, et al. Long-term follow-up of childhood lupus nephritis. J Rheumatol 29(12):2635-2642, 2002.
12. Cameron JS. Lupus nephritis. J Am Soc Nephrol 10(2):413-424, 1999.
13. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65(2):521-530, 2004.
14. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15(2):241-250, 2004.
15. Gloor JM. Lupus nephritis in children. Lupus 7(9):639-643, 1998.
16. Perfumo F, Martini A. Lupus nephritis in children. Lupus 14(1):83-88, 2005.
17. Bansal VK, Beto JA. Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kidney Dis 29(2):193-199, 1997.
18. Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC. Treatment for lupus nephritis. Cochrane Database Syst Rev 1: CD002922, 2004.
19. Marks SD, Shah V, Pilkington C, Woo P, Dillon MJ. Renal tubular dysfunction in children with systemic lupus erythematosus. Pediatr Nephrol 20(2):141-148, 2005.
20. Churg J, Sobin LH. Glomerulonephritis of systemic disease: lupus nephritis. In Renal Disease: Classification and Atlas of Glomerular Disease. Churg J and Sobin LH, eds. Tokyo: Igaku-Shoin, 127-149, 1982.
21. Churg J, Bernstein J, Glassock RJ. Renal Disease: Classification and Atlas of Glomerular Disease, 2nd ed. New York: Igaku-Shoin, 1995.
22. Schwartz MM, Lewis EJ. Rewriting the histological classification of lupus nephritis. J Nephrol 15 (Suppl 6):S11-S19, 2002.
23. Austin HA, III, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75(3):382-391, 1983.
24. Emre S, Bilge I, Sirin A, Kilicaslan I, Nayir A, Oktem F, et al. Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron 87(2): 118-126, 2001.
25. Khoo J, Pee S, Thevarajah B, Yap Y, Chin C. Lupus nephritis in children in Malaysia. J Paediatr Child Health 41(1-2):31-35, 2005.
26. Zappitelli M, Duffy C, Bernard C, Scuccimarri R, Watanabe DK, Kagan R, et al. Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol 19(5):503-510, 2004.
27. Donadio JV, Jr., Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 4(2):109-115, 1995.
28. Jacobsen S, Starklint H, Petersen J, Ullman S, Junker P, Voss A, et al. Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol 28(5):288-299, 1999.
29. MacGowan JR, Ellis S, Griffiths M, Isenberg DA. Retrospective analysis of outcome in a cohort of patients with lupus nephritis treated between 1977 and 1999. Rheumatology (Oxford) 41(9):981-987, 2002.
30. Yokoyama H, Wada T, Hara A, Yamahana J, Nakaya I, Kobayashi M, et al. The outcome and a new ISN=RPS 2003 classification of lupus nephritis in Japanese. Kidney Int 66(6):2382-2388, 2004.
31. Dumas R. Lupus nephritis. Collaborative study by the French society of paediatric nephrology. Arch Dis Child 60(2):126-128, 1985.
32. McCurdy DK, Lehman TJ, Bernstein B, Hanson V, King KK, Nadorra R, et al. Lupus nephritis: prognostic factors in children. Pediatrics 89(2):240-246, 1992.
33. Wang LC, Yang YH, Lu MY, Chiang BL. Retrospective analysis of the renal outcome of pediatric lupus nephritis. Clin Rheumatol 23(4):318-323, 2004.
34. Yang LY, Chen WP, Lin CY. Lupus nephritis in children - a review of 167 patients. Pediatrics 94(3):335-340, 1994.
35. Marks SD, Sebire NJ, Pilkington C, Tullus K. Clinicopathological correlations of paediatric lupus nephritis. Pediatr Nephrol 22:77-83, 2007.
36. Marks SD, Pilkington C, Woo P, Dillon MJ. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology (Oxford) 43(9):1186-1189, 2004.
37. Wright EC, Tullus K, Dillon MJ. Retrospective study of plasma exchange in children with systemic lupus erythematosus. Pediatr Nephrol 19(10):1108-1114, 2004.
38. Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, et al. Blymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arth Rheum 52(10):3168-3174, 2005.
39. Bates WD, Halland AM, Tribe RD, Rossouw DJ. Lupus nephritis. Part I. Histopathological classification, activity and chronicity scores. S Afr Med J 79(5):256-259, 1991.
40. Daniel L, Sichez H, Giorgi R, Dussol B, Figarella-Branger D, Pellissier JF, et al. Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis. Kidney Int 60(6):2215-2221, 2001.
41. Rush PJ, Baumal R, Shore A, Balfe JW, Schreiber M. Correlation of renal histology with outcome in children with lupus nephritis. Kidney Int 29(5):1066-1071, 1986.
42. Cheah PL, Kunaseegaran R, Looi LM. Expression of proliferating cell associated protein, Ki-67, supports cellular proliferation in WHO Class IV lupus nephritis. Malays J Pathol 23(1):27-30, 2001.
43. Negi VS, Aggarwal A, Dayal R, Naik S, Misra R. Complement degradation product C3d in urine: marker of lupus nephritis. J Rheumatol 27(2):380-383, 2000.
44. Holers VM. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. J Clin Invest 114(5):616-619, 2004.
45. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 16(2):467-473, 2005.